Guided Therapeutics (GTHP) Current Leases (2019 - 2026)
Guided Therapeutics (GTHP) posted Current Leases of $45000.0 for Q4 2025, down 40.79% sequentially from $76000.0 in Q3 2025, and down 57.55% YoY from $106000.0 in Q4 2024.
Guided Therapeutics (GTHP) Current Leases (2019 - 2026) Analysis & Trends
Guided Therapeutics has reported Current Leases for 7 years, with the latest figure at $45000.0 in Q4 2025.
- Quarterly Current Leases fell 57.55% year-over-year to $45000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $45000.0 (down 57.55% YoY) and the FY2025 annual result came in at $45000.0, down 57.55% from the prior year.
- Current Leases declined to $45000.0 in Q4 2025 per GTHP's latest filing, from $76000.0 in the prior quarter.
- Over five years, Current Leases peaked at $110000.0 in Q1 2025 and troughed at $42000.0 in Q1 2021.
- A 5-year average of $80800.0 and a median of $80500.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2022: Current Leases tumbled 57.58% in 2021, then jumped 66.67% in 2022.
- Over 5 years, Current Leases stood at $67000.0 in 2021, then gained by 17.91% to $79000.0 in 2022, then rose by 15.19% to $91000.0 in 2023, then grew by 16.48% to $106000.0 in 2024, then plunged by 57.55% to $45000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $45000.0, $76000.0, and $104000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 88,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 64,000.00 |
| Jun 30, 2021 | 62,000.00 |